financetom
Business
financetom
/
Business
/
Sunoco Spills the Beans: Big Beat, Higher Payout, & Brighter Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sunoco Spills the Beans: Big Beat, Higher Payout, & Brighter Outlook
May 8, 2024 10:13 AM

Sunoco LP ( SUN ) shares are trading higher after it reported first-quarter FY24 revenues of $5.50 billion, which exceeded the consensus of $5.23 billion.

The partnership sold over 2.1 billion gallons of fuel (+9% Y/Y), with the fuel margin for all gallons sold at 11.7 cents per gallon (vs 12.9 cents per gallon in the prior year quarter).

Adjusted distributable cash flow of $176 million was higher than $160 million a year ago.

Adjusted EBITDA increased to $242 million from $221 million a year ago. EPS of $2.26 surpassed the consensus of $1.22.

Total capital expenditures were $41 million, including $27 million for growth capital and $14 million for maintenance capital.

Distribution: On May 3, Sunoco ( SUN ) quarterly increased distribution by 4% to $0.8756 per unit, payable on May 20 to unitholders of record as of May 13.

As of March-end, the company had a long-term debt of $3.8 billion. The partnership maintained liquidity of approximately $870 million at the end of the quarter under its $1.5 billion revolving credit facility.  

Outlook: Sunoco ( SUN ) revised FY24 guidance for adjusted EBITDA to $1.46 billion to $1.52 billion, reflecting NuStar and Zenith acquisitions and divestiture.

In January 2024, the company disclosed a deal for selling 204 convenience stores to 7-Eleven for around $1 billion, including customary fuel and merchandise inventory adjustments. 

The NuStar deal is projected to boost Sunoco’s stability and credit profile and expects to realize at least $150 million in expenses and commercial synergies. 

Investors can gain exposure to the stock via InfraCap MLP ETF ( AMZA ) and Global X MLP ETF ( MLPA ) .

Price Action: Sunoco shares are trading up by 0.22% at $55.71 at the last check Wednesday. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Midland Exploration Starts Follow Up Program On Its New Discovery Of Gold-Zinc-Silver Mineralization at Caniapisc Au Project
Midland Exploration Starts Follow Up Program On Its New Discovery Of Gold-Zinc-Silver Mineralization at Caniapisc Au Project
Sep 23, 2025
09:29 AM EDT, 09/23/2025 (MT Newswires) -- Midland Exploration ( MIDLF ) announced Tuesday the start of a follow-up exploration program on its new discovery of gold, zinc, and silver on its Caniapisc Au project, in the Eeyou Istchee James Bay and Caniapiscau regions, and also announced map designation of two new projects in the same area. A statement noted...
Neurocrine Biosciences Says Ingrezza Shows Earlier Remission of Tardive Dyskinesia Symptoms
Neurocrine Biosciences Says Ingrezza Shows Earlier Remission of Tardive Dyskinesia Symptoms
Sep 23, 2025
09:29 AM EDT, 09/23/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Tuesday that a phase 4 open-label study confirmed robust rates of symptomatic remission of tardive dyskinesia with once-daily Ingrezza capsules. The analysis also showed sustained improvements in patient-reported outcomes among participants who achieved symptomatic remission, the company said. Shares of the company were down 1% in recent...
Solid Biosciences Signs Licensing Deal With Kinea Bio for AAV-SLB101 to Treat Muscular Dystrophy
Solid Biosciences Signs Licensing Deal With Kinea Bio for AAV-SLB101 to Treat Muscular Dystrophy
Sep 23, 2025
08:31 AM EDT, 09/23/2025 (MT Newswires) -- Solid Biosciences ( SLDB ) said Tuesday that it has signed a non-exclusive licensing and collaboration agreement with Kinea Bio to use Solid Biosciences' ( SLDB ) proprietary AAV-SLB101 to treat muscle tropism and reduced liver uptake. Under the terms of the deal, Solid has granted Kinea Bio a non-exclusive worldwide license to...
Connexi Expands Global Supply Chain Capabilities with Acquisition of Crown Agents Inspections Private Limited
Connexi Expands Global Supply Chain Capabilities with Acquisition of Crown Agents Inspections Private Limited
Sep 23, 2025
WASHINGTON and NEW DELHI, Sept. 23, 2025 /PRNewswire/ -- Connexi, Chemonics International's supply chain subsidiary, today announced the acquisition of Crown Agents Inspections Private Limited, or CA Inspections, a leading quality assurance and inspection services provider in India. The acquisition strengthens Connexi's ability to deliver end-to-end supply chain solutions, expanding its reach in Asia and enhancing its capacity for product...
Copyright 2023-2026 - www.financetom.com All Rights Reserved